Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Psoriasis is a common, chronic, and inflammatory skin disease. Macrophages account for about 61.3% of the inflammatory cells infiltrating psoriatic lesions. Modulating macrophage polarization, inhibiting their infiltration, and targeting the secretion of inflammatory factors and associated inflammatory pathways by these cells can alleviate psoriasis symptoms and inflammation. Moreover, nanomaterials as novel drug carriers, offer unique advantages such as large surface area, easy modification, high biocompatibility, good biodegradability, enhanced systemic adsorption, etc. Nanomaterials have great potential for efficient drug delivery and release, as well as improving therapeutic efficacy while reducing adverse effects. By systematically addressing the role of macrophages in psoriasis pathogenesis and the potential of nanomaterials in treating psoriasis through modulating macrophages, this review enhances our understanding of the disease mechanism and holds promise for novel therapeutic breakthroughs and advancements in the future treatment of psoriasis.
Vol 30, No 3 (2016) - Article
ENOX2 (or tNOX): A NEW AND OLD MOLECULE WITH CANCER ACTIVITY INVOLVED IN TUMOR PREVENTION AND THERAPY Abstract
Vol 30, No 4 (2016) - Article
Mast cell and cancer with special emphasis on il-37 an anti-inflammatory and inhibitor of innate immunity: new frontiers Abstract
Vol 31, No 3 (2017) - Article
Activation and inhibition of adaptive immune response mediated by mast cells Abstract
Vol 31, No 4 (2017) - Article
Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members Abstract
Vol 33, No 1 (2019) - Article
Interleukin-1 family cytokines and mast cells: activation and inhibition Abstract
Vol 34, No 2 (2020) - Article
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies Abstract
Vol 34, No 2 (2020) - Article
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1 Abstract
Vol 34, No 2 (2020) - Article
Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection Abstract
Vol 34, No 3 (2020) - Article
SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines Abstract
Vol 34, No 5 (2020) - Article
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra) Abstract
Vol 34, No 5 (2020) - Article
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19 Abstract
Vol 34, No 5 (2020) - Article
COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome? Abstract
Vol 34, No 6 (2020) - Article
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy Abstract
Vol 32, No 1 (2018) - Article
Different signals induce mast cell inflammatory activity: inhibitory effect of Vitamin E Abstract
Vol 33, No 6 (2019) - Article
CAR-T CELL THERAPY CAUSES INFLAMMATION BY IL-1 WHICH ACTIVATES INFLAMMATORY CYTOKINE MAST CELLS: ANTI-INFLAMMATORY ROLE OF IL-37 Abstract
Vol 32, No 2 (2018) - Article
Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37 Abstract
Vol 32, No 3 (2018) - Article
New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators Abstract
Vol 32, No 5 (2018) - Article
IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines Abstract
Vol 32, No 6 (2018) - Article
Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects Abstract
Vol 33, No 3 (2019) - Article
Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited? Details
Vol 27, No 4 (2013) - Article
Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy Abstract
Vol 26, No 3 (2012) - Article
Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells Abstract
Vol 25, No 2 (2011) - Article
The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines Abstract
In addition to the first issue that has already been published by the original publisher, there will be four more issues released this year, with scheduled publication dates in March, June, September, and December respectively.
Starting from Volume 39 Issue 2 (2025), the ownership of Journal of Biological Regulators and Homeostatic Agents (ISSN: 0393-974X (P); 1724-6083 (O)) will be transferred from Biolife Sas to Asia Pacific Academy of Science Pte. Ltd. As of 21 January 2025, authors should make submissions to the new journal system and follow the author guidelines. Asia Pacific Academy of Science Pte. Ltd. will take over the publication of manuscripts being processed.
